Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
Press releases
Press releases
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
28 found
Life-saving malaria project in Zambia to expand
25 Apr 2019
World Malaria Report highlights importance of country-led efforts to defeat malaria in highest burden countries
19 Nov 2018
MMV joins Swiss Malaria Group in Bern to commemorate World Malaria Day
25 Apr 2016
MMV announces collaborations with Cipla and Strides
27 Nov 2014
Campaign launched to help eliminate malaria deaths
23 Sep 2013
Winners of malaria photo contest announced
22 Apr 2013
Japan’s First PPP to Spearhead Innovation in Global Health
08 Apr 2013
New generation of lifesaving medicines and vaccines for the world’s poor now at risk
08 Dec 2011
Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities
11 Oct 2011
International status granted to three not-for-profit organizations in Switzerland
09 Dec 2010
MMV 10th Anniversary Seminars: presentations and video clips
04 Dec 2009
MMV’s President and CEO to step down in 2010
23 Nov 2009
MMV and Novartis launch Coartem®
Dispersible
20 Feb 2009
MMV and Novartis launch Coartem®
Dispersible
in Africa
15 Feb 2009
Unique collaboration launches a new malaria medicine to save millions of children
27 Jan 2009
Malaria Map: New Tool for Malaria Control
06 Dec 2006
Medicines for Malaria Venture, Higher Colleges of Technology and Global Medical Forum Foundation Collaborate on Innovative Abu Dhabi Bio City Research Initiative to Tackle Malaria
18 Oct 2006
MMV announces a commitment of US$50 million to advance malaria research at President Clinton’s Global Initiative
21 Sep 2006
MMV Stakeholders’ Meeting - Shin Poong Pharm. wins Project of the Year
06 May 2006
MMV applauds WHO’s call to halt malaria monotherapy
23 Jan 2006
Dr Pascoal Manuel Mocumbi, Prime Minister of Mozambique, joins MMV Board
13 Oct 2003
Medicines for Malaria Venture and GlaxoSmithKline (GSK) team up to fight malaria in developing countries
13 Jun 2003
All press clippings from MMV’s 3rd Annual Stakeholders’ Meeting
18 May 2003
MMV appoints two new Board Members
20 Dec 2001
MMV to build malaria research capacity in India
28 Sep 2001
MMV - A new player in the battle against malaria
12 Jun 2001
MMV announces core management team
12 Jan 2001
WHO, partner agencies and industry launch unique venture to develop malaria drugs
03 Nov 1999